Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Australis Capital Inc C.AUSA

Alternate Symbol(s):  AUSAF

Australis Capital Inc. is a multi-state operator in the cannabis industry in the United States. The Company is involved in the cannabis and horticultural industries in the United States and abroad. It is focused on brands and cannabis licenses in states with favorable economics. The Company also operates an engineering consulting firm. The Company advises on greenhouse design, build and operations throughout the world in cannabis and horticulture. Its operations range from providing sustainable cultivation design and optimization to retail storefronts, growing flowers in-house, and manufacturing brand, AUDACIOUS has products and solutions for everyone.


CSE:AUSA - Post by User

Bullboard Posts
Post by oilcan2012on Oct 16, 2020 10:08am
208 Views
Post# 31727666

AUSA-Launch of SPAC/Commentary

AUSA-Launch of SPAC/Commentary

"We plan to quickly launch a dual listed (Canada and the US) SPAC with the goal of raising $75M to $100M..."

Significant.  Who has the track record to be able to set one of these up?  Booth or DeMott? Access to capital is critical, especially as it relates to dilution and shareholder value. Secondly, it will allow AUSA to acquire operating businesses they can grow. 

As the AUSA circular points out, Booth et al have incestious ties to GT and Nutritional High, the latter being dubious at best, the value proposition clearly out of sync with market acceptability. ~600m outstanding shares, $.015 (stock reached a high of $.034 in 2019 and has been in decline ever since.) Jason Dyck, Adam Szweras, Duke Fu...contributors. And they would benefit AUSA how?  (Don't understand how Dyck would want to imperil his brand/reputation on this? https://www.ualberta.ca/medicine/about/people/details.html?n=jason-dyck  ) 

Then there is Duke Fu, referencing the circular, who wants his soother back and will clearly react to whatever serves his interests, not the shareholders. Unbelievable. 

As a shareholder of AUSA, this appears to be the clown show of clown shows. Regretably, Booth has little credibility left, a daunting legacy of a ~$3.3 billion ACB write off. Don't understand why he would want to subject himself to this. Could he not have acted with reason and wisdom?

References:

  • https://www.investopedia.com/terms/s/spac.asp
  • https://www.ausarejectdissidents.com/docs/Australis-2020-AGM-Information-Circular.pdf
  • https://corpgov.law.harvard.edu/2018/07/06/special-purpose-acquisition-companies-an-introduction/
  • https://www.thecse.com/en/listings/life-sciences/nutritional-high-international-inc

 


Bullboard Posts